Literature DB >> 10090289

Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes.

J Zeng1, H R Treutlein, T Simonson.   

Abstract

The protein Raf is an immediate downstream target of Ras in the MAP kinase signalling pathway. The complex of Ras with the Ras-binding domain (RBD) of Raf has been modelled by homology to the (E30D,K31E)-Rap1A:RBD complex, and both have been subjected to multiple molecular dynamics simulations in solution. While both complexes are stable, several rearrangements occur in the Ras:RBD simulations: the RBD loop 100-109 moves closer to Ras, Arg73 in the RBD moves towards Ras to form a salt bridge with Ras-Asp33, and Loop 4 of the Ras switch II region shifts upwards toward the RBD. The Ras:RBD interactions (including the RBD-Arg73 interaction) are consistent with available NMR and mutagenesis data on the Ras: RBD complex in solution. The Ras switch II region does not interact directly with the RBD, although indirect interactions exist through the effector domain and bridging water molecules. No large-scale RBD motion is seen in the Ras:RBD complex, compared to the Rap:RBD complex, to suggest an allosteric activation of Raf by Ras. This may be because the Raf kinase domain (whose structure is unknown) is not included in the model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090289

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  3 in total

Review 1.  Endothelin and the "seventh inning stretch".

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

2.  Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling.

Authors:  Shuai Li; Hyunbum Jang; Jian Zhang; Ruth Nussinov
Journal:  Structure       Date:  2018-02-08       Impact factor: 5.006

3.  The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors.

Authors:  Teklab Gebregiworgis; Yoshihito Kano; Jonathan St-Germain; Nikolina Radulovich; Molly L Udaskin; Ahmet Mentes; Richard Huang; Betty P K Poon; Wenguang He; Ivette Valencia-Sama; Claire M Robinson; Melissa Huestis; Jinmin Miao; Jen Jen Yeh; Zhong-Yin Zhang; Meredith S Irwin; Jeffrey E Lee; Ming-Sound Tsao; Brian Raught; Christopher B Marshall; Michael Ohh; Mitsuhiko Ikura
Journal:  Nat Commun       Date:  2021-11-01       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.